CONCENTRIX CORP's ticker is CNXC and the CUSIP is 20602D101. A total of 329 filers reported holding CONCENTRIX CORP in Q2 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,772,577 | +894.9% | 75,420 | +941.1% | 0.00% | – |
| Q1 2024 | $479,698 | -91.0% | 7,244 | -86.7% | 0.00% | -100.0% |
| Q4 2023 | $5,352,740 | +347.7% | 54,503 | +265.2% | 0.00% | – |
| Q3 2023 | $1,195,562 | +41.3% | 14,924 | +42.4% | 0.00% | – |
| Q2 2023 | $846,260 | -84.5% | 10,480 | -76.7% | 0.00% | -100.0% |
| Q1 2023 | $5,475,463 | +41.3% | 45,047 | +29.7% | 0.00% | 0.0% |
| Q3 2022 | $3,876,000 | +65.6% | 34,726 | +101.2% | 0.00% | +100.0% |
| Q2 2022 | $2,341,000 | -83.0% | 17,257 | -79.2% | 0.00% | -75.0% |
| Q1 2022 | $13,787,000 | +157.8% | 82,775 | +176.5% | 0.00% | +300.0% |
| Q4 2021 | $5,348,000 | +319.8% | 29,941 | +315.9% | 0.00% | – |
| Q3 2021 | $1,274,000 | +147.4% | 7,199 | +125.0% | 0.00% | – |
| Q2 2021 | $515,000 | -49.3% | 3,200 | -52.8% | 0.00% | -100.0% |
| Q1 2021 | $1,015,000 | +381.0% | 6,776 | +216.9% | 0.00% | – |
| Q4 2020 | $211,000 | – | 2,138 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Groupe Bruxelles Lambert | 8,773,667 | $555,197,648 | 100.00% |
| Impactive Capital LP | 3,846,370 | $243,398,294 | 9.46% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 623,542 | $39,457,738 | 1.80% |
| LYRICAL ASSET MANAGEMENT LP | 1,271,250 | $80,444,700 | 1.29% |
| Copeland Capital Management, LLC | 985,722 | $62,376,533 | 1.17% |
| Nierenberg Investment Management Company, Inc. | 27,910 | $1,766,145 | 0.99% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 564,732 | $35,736,207 | 0.97% |
| VALLEY WEALTH MANAGERS, INC. | 168,482 | $10,661,541 | 0.85% |
| Bragg Financial Advisors, Inc | 202,698 | $12,826,730 | 0.57% |
| CLARK ESTATES INC/NY | 44,250 | $2,800,140 | 0.53% |